Polycystic ovary syndrome
Conditions
Interventions
Group A1:Anovulatory patients with endometrium =10mm: Xiaonangtiaojing Huoxue recipe was taken orally for 14 days. Observe whether menstruation comes.If menstruation doesn't comes, Dydrogesterone was
Group A2:Anovulatory patients with endometrium =10mm:Xiaonangtiaojing Huatan recipe was taken orally for 14 days. Observe whether menstruation comes.If menstruation doesn't comes, Dydrogesterone was g
Group B1:Anovulatory patients with 7mm= endometrium < 10mm or more.: Xiaonangtiaojing Huoxue recipe was taken orally for 14 days. Observe whether menstruation comes.If menstruation doesn't comes, Dydr
Group B2:Anovulatory patients with 7mm= endometrium < 10mm or more.:Xiaonangtiaojing Huatan recipe was taken orally for 14 days. Observe whether menstruation comes.If menstruation doesn't comes, Dydro
Group C1:Anovulatory patients with endometrium < 7 mm: Xiaonangtiaojing Huoxue recipe was taken orally for 14 days. Observe whether menstruation comes.If menstruation doesn't comes, Dydrogesterone was
Group C2:Anovulatory patients with endometrium < 7 mm:Xiaonangtiaojing Huatan recipe was taken orally for 14 days. Observe whether menstruation comes.If menstruation doesn't comes, Dydrogesterone was
menstruation comes pcos group(A+B+C):30 patients with menstrual cramps were selected from the above (A+B+C) group.On the third day of menstruation, oral Xiaonangtiaojing Huatan reci
Sponsors
First Affiliated Hospital, Heilongjiang University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1.Those who meet the diagnostic criteria of western medicine (PCOS, overweight and obesity) and TCM syndrome differentiation criteria; 2.Female aged 18-45 (with sexual history); 3.There was no history of using hormone drugs or drugs affecting glucose and lipid metabolism in the three months before the start of treatment; 4.Volunteer to participate in this experiment and sign the informed consent form; 5.Patients who have no unplanned pregnancy requirements and can be followed up.
Exclusion criteria
Exclusion criteria: 1.Reproductive organ cancer or other local or systemic malignant tumors, or genital tuberculosis and deformity; 2.Suffering from serious diseases such as cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system; 3.Those who receive multiple other treatments at the same time; 4.Those who have been treated with hormones and related drugs in the past three months or patients with uncontrolled chronic diseases; 5.Mental disorders, combined with mental illness can not express the condition; 6.Late menstruation caused by other reasons; 7.Those who do not meet the diagnostic criteria and inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TVS-3D Observability Index;Sex hormone index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycolipid metabolism index ;Body fat analysis (In Body770);questionnaire survey;Related blood indicators; | — |
Countries
China
Contacts
Public ContactSun Miao
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Outcome results
None listed